Header cover image

Pharmaceuticals & Biotech Top Rated Asian Stocks

Results

15

2 new

Financially healthy companies listed on Asian stock exchanges with an impressive track record.

15 companies

Laurus Labs

Market Cap: ₹987.9b

Manufactures and sells medicines and active pharmaceutical ingredients (APIs) in India and internationally.

LAURUSLABS

₹1,830.00

7D

2.7%

1Y

118.3%

Biocytogen Pharmaceuticals (Beijing)

Market Cap: HK$50.9b

A biotechnology company, engages in the research and development of novel antibody-based drugs and pre-clinical research services in the People’s Republic of China, the United States, and internationally.

2315

HK$55.55

7D

15.3%

1Y

126.0%

Anthem Biosciences

Market Cap: ₹465.0b

Operates as a contract research, development, and manufacturing organization in India, rest of Asia, North America, Europe, and internationally.

ANTHEM

₹825.65

7D

5.3%

1Y

10.1%

Emcure Pharmaceuticals

Market Cap: ₹367.2b

Emcure Pharmaceuticals Limited provide quality and affordable healthcare solutions worldwide.

EMCURE

₹1,936.70

7D

1.4%

1Y

38.3%

Neuland Laboratories

Market Cap: ₹275.8b

Engages in the manufacture and sale of active pharmaceutical ingredients (APIs) in India, Europe, the United States, and internationally.

524558

₹21,499.95

7D

11.9%

1Y

67.5%

Acutaas Chemicals

Market Cap: ₹266.9b

Engages in the research and development, manufacture, and sale of pharmaceutical intermediates in India and internationally.

ACUTAAS

₹3,260.60

7D

0.8%

1Y

151.8%

Rubicon Research

Market Cap: ₹253.8b

Operates as a specialty pharmaceutical company in India, the United States, and internationally.

RUBICON

₹1,533.40

7D

2.2%

1Y

n/a

Aether Industries

Market Cap: ₹210.3b

Produces and sells advanced intermediates and specialty chemicals in India and internationally.

AETHER

₹1,584.40

7D

6.3%

1Y

111.7%

Granules India

Market Cap: ₹207.7b

Manufactures and sells active pharmaceutical ingredients (APIs), pharmaceutical formulation intermediates (PFIs), finished dosages (FDs), and peptides CDMO in India and internationally.

532482

₹838.20

7D

0.5%

1Y

86.5%

Jinyu Bio-technology

Market Cap: CN¥14.3b

Engages in the research and development, production, and sale of veterinary biological products in China and internationally.

New

600201

CN¥13.09

7D

11.7%

1Y

51.3%

Inner Mongolia Furui Medical Science

Market Cap: CN¥11.4b

Inner Mongolia Furui Medical Science Co., Ltd.

300049

CN¥43.07

7D

-0.9%

1Y

-12.1%

Shilpa Medicare

Market Cap: ₹144.7b

Manufactures and sells active pharmaceutical ingredients (APIs), finished dosage formulations, biosimilars, and contract development and manufacturing organisation in India, the United States, Europe, and internationally.

530549

₹740.05

7D

22.6%

1Y

80.5%

Viyash Scientific

Market Cap: ₹119.1b

Operates as a veterinary pharmaceutical Company in India, the United States, Spain, and internationally.

512529

₹272.90

7D

8.3%

1Y

55.9%

Strides Pharma Science

Market Cap: ₹91.9b

A pharmaceutical company, engages in the development, manufacturing, and marketing of pharmaceutical products in North America, Australia, Africa, Europe, India, the rest of Asia, and internationally.

STAR

₹997.20

7D

-7.0%

1Y

24.9%

Sakar Healthcare

Market Cap: ₹20.5b

Research, develops, manufactures, and sells pharmaceutical products in India.

New

SAKAR

₹919.70

7D

8.9%

1Y

172.9%